-
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial: The BRDME Study, a Randomized Trial
Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group, Aug 2020, In: Ophthalmology Retina. 4, 8, p. 777-788 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial
Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group, Jun 2020, In: Ophthalmology Retina. 4, 6, p. 576-587 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trial
Buitendijk, G. H. S., Schauwvlieghe, A-S. M. E., Vingerling, J. R., Schlingemann, R. O. & Klaver, C. C. W., 2018, In: American Journal of Ophthalmology. 187, p. 130-137Research output: Contribution to journal › Article › Academic › peer-review
- All publications
